O. CHOW Et Al. , "KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.," Annals of surgical oncology , vol.23, pp.2548-55, 2016
CHOW, O. Et Al. 2016. KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.. Annals of surgical oncology , vol.23 , 2548-55.
CHOW, O., KUK, D., Keskin, M., SMITH, J., CAMACHO, N., PELOSSOF, R., ... CHEN, C.(2016). KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.. Annals of surgical oncology , vol.23, 2548-55.
CHOW, OS Et Al. "KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.," Annals of surgical oncology , vol.23, 2548-55, 2016
CHOW, OS Et Al. "KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.." Annals of surgical oncology , vol.23, pp.2548-55, 2016
CHOW, O. Et Al. (2016) . "KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.." Annals of surgical oncology , vol.23, pp.2548-55.
@article{article, author={OS CHOW Et Al. }, title={KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.}, journal={Annals of surgical oncology}, year=2016, pages={2548-55} }